![](https://cdn.wionews.com/sites/default/files/2024/08/08/448122-illumina.jpg)
Illumina says slumping sales in core segment expected as demand softens, economy weighs
Illumina, the biggest seller of gene sequencing machines, gave a weak outlook for sales in its central business in 2024. According to the company, genetic testing instruments will continue to see lacklustre demand all year. The tepid demand for tools and …